The Medicare Prescription Drug Inflation Rebate Program will lower coinsurance for Medicare Part B beneficiaries for certain drugs, with savings between $2 and $390 per average dose starting April 1.

American College of Cardiology Vice President Cathie Biga spoke to Cardiovascular Business about why the organization wants to get more involved in the business side of cardiology.

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

For the first time, Medicare will have the ability to negotiate prices of certain medications. These negotiations will focus on key questions such as the drug's benefits, the extent to which it fulfills an unmet medical need and its impact on Medicare beneficiaries.

The Medicare Payment Advisory Commission (MedPAC) wants to tie physician payments to inflation. Healthcare groups say it doesn't go far enough

A significant portion of U.S. adults have some past-due medical debt, according to a recent study from the Urban Institute, and the majority of those with debt owe non-profit hospitals.

The Food and Drug Administration has put in for a $7.2 billion chunk of the $6.9 trillion federal budget for fiscal year 2024 that President Joe Biden proposed March 9.

"Margins are not expected to return to pre-pandemic levels for quite some time," according to a new report.